Despite the advent of many new technologies in aiding the diagnosis and treatment of glaucoma, glaucoma remains an important cause of world blindness.1–3 Although minimally invasive glaucoma surgeries are becoming more popular, trabeculectomy remains the most effective incisional surgical method for lowering intraocular pressure.4–6 According to Primary Open-angle Glaucoma Preferred Practice Pattern published in 20207 and the third edition of the Asia Pacific Glaucoma Guidelines,8 trabeculectomy can also be considered in suitable cases as first-line surgical therapy.
The effectiveness of trabeculectomy depends on the formation of a functional filtering bleb. Mitomycin C (MMC) was first introduced for intraoperative use in trabeculectomy by Chen et al9 in 1983. With an antifibrotic effect, it reduces subconjunctival scarring, and is recognized to significantly improve the likelihood of functional bleb formation.10 At present, it is a widely used adjunct to trabeculectomy.11
Application of MMC is mostly by direct application to the scleral bed by MMC-soaked sponge, although subconjunctival injection has also been used, to a much less extent. Although some studies showed that there was no significant difference regarding safety between the two methods,12–14 the direct sponge method is well accepted in clinical practice and considered as the conventional and benchmark method. The conventional method of MMC-soaked sponge placement may lead to bleb-related complications.15 The using of large and irregular sponges, and their improper positioning, as well as high concentrations of MMC,16 can cause complications, including: hypotony, bleb leakage,17 and blebitis;18 limited reoperation area due to thin avascular conjunctiva and surrounding scarring from exposure to MMC; or limbus or corneal degeneration (Figs. 1–3). Although Peng Khaw et al have proposed a recommended method of MMC application in which the sponge should cover the largest possible area to create a more diffused bleb and prevent the development of a posterior limiting scar (ring of steel) or cystic bleb,19 this method might cause excessive conjunctival trauma and make it difficult to reoperate on the area. More bleb-related complications might be related to oversized conjunctival incision and the largest area of MMC application in the long run. Here, a modified, practical method of using MMC-soaked sponge is proposed to improve the surgical outcomes. In brief, a sponge with a dimension of 3.5 mm × 10 mm soaked with MMC is placed vertically and posteriorly with the long side of the sponge perpendicular to the limbus, not parallel (Figs. 4C1 and 5). The exact MMC concentration and duration of application will be decided by the operating surgeon. The detailed surgical techniques are shown in Figure 5 and the attached Supplementary Digital Content, https://links.lww.com/APJO/A107 and https://links.lww.com/APJO/A108)
With this method of application of the MMC-soaked sponge, we have the following observations:
- (1) the drainage direction of aqueous humor changed from sequestrated at the limbus to the posterior fornix, forming a posteriorly directed filtering tunnel;
- (2) the conjunctival incision was limited and the opportunity of secondary operation can be achieved;
- (3) the chance of corneal and limbal involvement is reduced. The postoperative effect is shown in Figure 6.
This modified method has several potential advantages. First of all, this method causes minimal damage to the conjunctiva with limited surgical trauma within the incision field. Secondly, the more posterior positioning of the sponge may make the filtering bleb diffuse and reduces the risk of bleb-related complications to the maximum extent, particularly reducing the risk of forming the “ring of steel” scarring and cystic bleb. The method is quantitative in the size and positioning of the sponge, and the incubation time and the concentration of MMC could be altered according to the surgeons’ preferred choice, in which the characterized information of patients should be considered.
Placing the long side of the MMC-soaked sponge perpendicular to the corneal limbus may lead to effective functional filtering blebs formation, reduce conjunctival injury and the incidence of bleb-related complications. Long-term observation and further evaluation of the safety and efficacy of this modified technique of applying the MMC-soaked sponge during trabeculectomy through large-scale, randomized control trials seem warranted.
1. Taylor HR. Global blindness: the progress we are making and still need to make. Asia Pac J Ophthalmol (Phila)
2. Ha A, Park KH. Optical coherence tomography for the diagnosis and monitoring of glaucoma. Asia Pac J Ophthalmol (Phila)
3. Moghimi S, Hou H, Rao H, et al. Optical coherence tomography angiography and glaucoma: a brief review. Asia Pac J Ophthalmol (Phila)
4. Singh K, Sherwood MB, Pasquale LR. Trabeculectomy
must survive!. Ophthalmol Glaucoma
5. Sheheitli H, Tirpack AR, Parrish RKII. Which patients would most likely to benefit: MIGs or MEGs, which one is it? Asia Pac J Ophthalmol (Phila)
6. Gillmann K, Mansouri K. Minimally invasive glaucoma surgery: where is the evidence? Asia Pac J Ophthalmol (Phila)
7. Gedde SJ, Vinod K, Wright MM, et al. Primary open-angle glaucoma Preferred Practice Pattern®. Ophthalmology
8. Aung T, Crowston J. Asia Pacific Glaucoma Guidelines. Amsterdam, Netherlands: Kugler Publications; 2016.
9. Chen CW. Enhanced intraocular pressure controlling effectiveness of trabeculectomy
by local application of mitomycin-C. Trans Asia Pacific Acad Ophthalmol
10. Palmer SS. Mitomycin as adjunct chemotherapy with trabeculectomy
11. Vinod K, Gedde SJ, Feuer WJ, et al. Practice preferences for glaucoma surgery: a survey of the American Glaucoma Society. J Glaucoma
12. Do JL, Xu BY, Wong B, et al. A randomized controlled trial comparing subconjunctival injection to direct scleral application of Mitomycin C in trabeculectomy
. Am J Ophthalmol
13. Kandarakis SA, Papakonstantinou E, Petrou P, et al. 1-year randomized comparison of safety and efficacy of trabeculectomy
with MMC subtenon injection versus MMC-infused sponges. Ophthalmol Glaucoma
14. Esfandiari H, Pakravan M, Yazdani S, et al. Treatment outcomes of Mitomycin C-augmented trabeculectomy
, sub-tenon injection versus soaked sponges, after 3 years of follow-up: a randomized clinical trial. Ophthalmol Glaucoma
15. Jampel HD, Solus JF, Tracey PA, et al. Outcomes and bleb-related complications of trabeculectomy
16. Kitazawa Y, Suemori-Matsushita H, Yamamoto T, et al. Low-dose and high-dose mitomycin trabeculectomy
as an initial surgery in primary open-angle glaucoma. Ophthalmology
17. Laspas P, Wahl J, Peters H, et al. Outcome of bleb revision with autologous conjunctival graft alone or combined with donor scleral graft for late-onset bleb leakage with hypotony after standard trabeculectomy
with Mitomycin C. J Glaucoma
18. Razeghinejad MR, Havens SJ, Katz LJ. Trabeculectomy
bleb-associated infections. Surv Ophthalmol
19. Khaw PT, Chiang M, Shah P, et al. Enhanced trabeculectomy
: the Moorfields Safer Surgery System. Dev Ophthalmol